Subscribe To
Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions
– Once-weekly administration of CT-388 delivers clinically meaningful weight loss and metabolic control with a favorable tolerability profile over a 4 week treatment period in overweight and obese otherwise healthy participants – – Mechanism of Action study achieves robust weight-independent effect of CT-868 on glucose homeostasis in overweight and obese adults with type 2 diabetes […] The post Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments for Obesity and Diabetes...
Read More
Posted: Jun 24 2023, 01:30
Author Name: forextv
Views: 081032